Rita De Santis
Sigma Tau SpA, Italy
Biography
Rita De Santis has a degree in Biological Sciences and PhD in Experimental Medicine from Rome University and National Institutes of Health, USA, respectively. Since 1999, she directs the group of Biotech Products at Sigma Tau SpA, leading innovative products from bench to clinical trials. She is the author of 70 papers and 20 patents. Her work focuses on the development of the AvidinOX-based therapeutic platform for cancer therapy and looking for collaborations to fully exploit the potential of AvidinOX for targeted delivery of biotinylated drugs in additional therapeutic fields.